Chongqing Changshou Manufacturing Site Global Presence

Global Presence

Chongqing Changshou Manufacturing Site

As the small molecule drug substance GMP facilities, we consists of Production, Technology, Quality, EHS, Supply chain management and Equipment departments.

1 Fine Chemical Zone, Changshou District, Chongqing, China

2005Founded

It is a flagship API plant of Porton.

64,480m²Area

There are 11 workshops under operation at the Changshou site, operating 24 hours a day, 7 days a week.

834.3m³Total Capacity

The reactor volume ranges from 5L to 10,000L, delivering products from kilograms to metric tons.

Offering

Capabilities Services

Capabilities

Temperature Range from -20℃ to 120℃
Cryogenic down to -90℃
High Temperature up to 200℃
Hydrogenation up to 60 bar
High Vacuum Thin Film Evaporator
Column Chromatograph
Flow Manufacturing
Distillation Column for Liquid Product Purification
OEB 4 Compound Handling with ECM "ment and production of small molecule APIs, as well as technical services throughout the entire lifecycle from pre-clinical to commercial to our worldwide partners.

Services

Tides Description

Capabilities

Temperature Range from -20℃ to 120℃/li>
Cryogenic down to -90℃/li>
High Temperature up to 200℃
Hydrogenation up to 60 bar
High Vacuum Thin Film Evaporator
Column Chromatograph
Flow Manufacturing
Distillation Column for Liquid Product Purification
OEB 4 Compound Handling with ECM

Chongqing Changshou Manufacturing Site F

Services

Small Molecule

Porton offers efficient, flexible, and high-quality solutions for custom development and production of small molecule APIs, as well as technical services throughout the entire lifecycle from pre-clinical to commercial stages to our worldwide partners.

Facilities

Video

One Porton One Quality

Track Records of Inspections and Audits

We engage in implementing quality management throughout the lifecycle of the product from R&D, production, control, to release. Directed by customer needs, the Changshou site has passed inspections conducted by NMPA, USFDA, PMDA, WHO, and EMA and will maintain its quality commitment of "System compliance, continuous improvement, and customer orientation."

SME Teams

In the drug lifecycle, drug development, production, and regulation are highly complex and specialized. Porton has established a professional SME team that has accumulated profound knowledge and experience in technology, regulations, and business. This ensures that Porton remains competitive in a highly regulated market, delivering efficient and compliant solutions and services.

Case Studies

ENT-03 GRC Poster

How Porton's Expertise Enhances Mutual Benefits in License In/Out Agreements

News

News2024-11-13

Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials.

News2024-11-09

Porton’s New Modality Capacity Upgrade Ceremony Successfully Held

News2024-10-31

Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai

News2024-10-24

Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar

News2024-10-14

Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review

News2024-10-10

Connect with Porton J-STAR at AAPS PharmSci 360 2024 @ Booth 2431

News2024-09-30

Technical Enability | Porton's Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference

Chongqing Changshou Manufacturing Site Global Presence - PORTON